Product logins

Find logins to all Clarivate products below.


Interventional Oncology Devices | Market Insights | US | 2024

The US market for interventional oncology devices will grow through 2032. This will be driven largely by the increasing shift toward higher-priced technologies, such as radioembolization, and expanding populations that are treatable with ablation.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for interventional oncology devices in the US from 2019 through 2032.

Related Medtech Insights Reports

Report
Interventional Oncology Devices – Market Insights – Asia Pacific (Supplemental)
The Asia Pacific interventional oncology device market will see strong growth through 2033, driven by large and rapidly expanding patient population, increasing popularity of minimally invasive…
Report
Interventional Oncology Devices – Market Insights – Europe (Supplemental)
The European interventional oncology device market will see modest growth through 2033, driven by increasing incidence and prevalence rates of cancer, cost-effectiveness of ablation and…
Report
Interventional Oncology Devices – Market Insights – United States
The US market for interventional oncology devices will be driven by uptake of advanced and higher-priced technologies—such as radioembolization—favorable clinical data, expanding populations…
Report
Interventional Oncology Devices – Market Insights – Europe
The European interventional oncology device market will see modest growth through 2033, driven by increasing incidence and prevalence rates of cancer, cost-effectiveness of ablation and…
Report
Interventional Oncology Devices – Market Insights – Japan
Although the interventional oncology procedure volumes are increasing marginally in Japan, the Japanese interventional oncology device market will decline due to limited adoption of minimally…